Methylene diphosphonate
From Wikipedia, the free encyclopedia
Methylene diphosphonate
|
|
Systematic (IUPAC) name | |
phosphonomethylphosphonic acid | |
Identifiers | |
CAS number | |
ATC code | ? |
PubChem | |
Chemical data | |
Formula | CH6O6P2 |
Mol. mass | 176.002 g/mol |
Pharmacokinetic data | |
Bioavailability | ? |
Metabolism | ? |
Half life | ? |
Excretion | ? |
Therapeutic considerations | |
Pregnancy cat. |
? |
Legal status | |
Routes | ? |
Methylene diphosphonate (MDP or medronic acid) is a pharmaceutical product used especially in nuclear medicine, linked to 99mTc, as a marker to avoid the Single Photon Emission Scintigraphy, or SPECT, to localize carcinogentic bone metastasis as well as other diseases that can alter the natural turn-over in bone.
|